机译:治疗预后因素和脊髓星形细胞瘤的预后
Baylor College of Medicine, Waco, Texas;
Department of Radiation Oncology,University of Texas MD Anderson Cancer Center, Houston, Texas;
Department of Neuro-oncology,University of Texas MD Anderson Cancer Center, Houston, Texas;
Department of Neurosurgery, University of Texas MD Anderson Cancer Center, Houston, Texas;
Department of Neurosurgery, University of Texas MD Anderson Cancer Center, Houston, Texas;
Department of Neuro-oncology,University of Texas MD Anderson Cancer Center, Houston, Texas;
Department of Radiation Oncology, Unit 97, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX 77030;
chemotherapy; glioma; intramedullary; management prognosis;
机译:手术切除成人髓内脊髓星形细胞瘤后的分子和临床预后因素
机译:成人髓内脊髓星形细胞瘤外科手术切除后的有利结果的分子和临床预后因素
机译:手术和保守治疗有症状脊髓海绵状畸形预后的预后因素:一系列20例患者的审查
机译:基于胶原蛋白的多式联运系统为治疗大鼠脊髓损伤提供了治疗因素和物理支持
机译:青少年在住院治疗中的症状状态和危险因素:制定青年结局问卷(Y-OQ)规范,确定Y-OQ和Y-OQ预后评估(Y-OQ PA)在预测治疗环境中的效用
机译:脊髓星形细胞瘤的治疗预后因素和结果
机译:脊髓原发性恶性星形细胞瘤的预后因素和生存